Citadel Advisors »

Inozyme Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $309k 59k 5.23
2024-06-30 $134k 30k 4.46
2024-03-31 $768k 100k 7.66
2023-12-31 $745k 175k 4.26
2023-09-30 $712k 170k 4.20
2023-06-30 $945k 170k 5.57
2023-03-31 $4.7M 823k 5.73
2022-06-30 $577k 121k 4.77
2022-03-31 $402k 98k 4.09
2021-12-31 $729k 107k 6.82
2021-09-30 $1.1M 95k 11.59
2021-06-30 $2.9M 171k 17.03
2021-03-31 $4.7M 240k 19.68
2020-12-31 $5.2M 253k 20.64
2020-09-30 $6.3M 241k 26.29